Recognized standard
F2027-16
FDA recognition 15-49 · ASTM · Tissue Engineering
Key facts
| Recognition number | 15-49 |
|---|---|
| Designation | F2027-16 |
| Title | Standard Guide for Characterization and Testing of Raw or Starting Materials for Tissue-Engineered Medical Products |
| Standards developer | ASTM International |
| Specialty area | Tissue Engineering |
| Date of entry | Aug 21, 2017 |
| Scope (excerpt) | 1.1 This document provides guidance on writing a materials specification for raw or starting materials intended for use in tissue engineering scaffolds for growth, support, or delivery of cells and/or biomolecules. This guide does not apply to materials that are already in a scaffold form or are… |
At a glance
- None Product codes
- 1–9 FDA guidance documents
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA-recognized consensus standards
The FDA recognizes voluntary consensus standards that manufacturers can cite in premarket submissions to show conformity with specific requirements.
Source: U.S. Food and Drug Administration (FDA), Recognized Consensus Standards database · Source date: